| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 0 | 8.989 | 12.700 | 14.072 | 22.522 | 18.354 | 17.939 | 15.199 |
| Total Income - EUR | - | - | 0 | 8.989 | 12.700 | 14.077 | 22.523 | 20.323 | 17.943 | 15.218 |
| Total Expenses - EUR | - | - | 212 | 3.327 | 6.505 | 15.535 | 17.714 | 20.727 | 14.295 | 16.980 |
| Gross Profit/Loss - EUR | - | - | -212 | 5.662 | 6.195 | -1.458 | 4.809 | -404 | 3.648 | -1.761 |
| Net Profit/Loss - EUR | - | - | -212 | 5.392 | 5.814 | -1.859 | 4.147 | -955 | 2.008 | -2.746 |
| Employees | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Nefroped Team Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 80 | 0 | 47.273 | 38.539 | 30.019 | 22.585 | 14.647 | 6.879 |
| Current Assets | - | - | 48 | 5.339 | 88 | 534 | 1.783 | 1.715 | 6.180 | 3.803 |
| Inventories | - | - | 0 | 703 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 0 | 0 | 0 | 356 | 206 | 1.904 | 75 |
| Cash | - | - | 48 | 4.636 | 88 | 534 | 1.427 | 1.509 | 4.275 | 3.728 |
| Shareholders Funds | - | - | -168 | 5.227 | 10.940 | 8.874 | 12.824 | 11.909 | 9.959 | 7.158 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | 296 | 112 | 36.421 | 30.198 | 18.978 | 12.391 | 10.867 | 3.525 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Nefroped Team Srl